Trends in nanobody technology in industrialization

Abstract Antibodies, which are important research entities in the field of biopharmaceuticals, hold a key position in the global pharmaceutical market. Nanobodies [a single-domain antibody (VHH)] have gradually shown unique advantages due to their specificity, small molecule size, high affinity, goo...

Full description

Bibliographic Details
Published in:	Discover Nano
Main Author:	Yuhao Wu
Format:	Article
Language:	English
Published:	Springer 2025-02-01
Subjects:	Nanobody Patent Clinical trial Product Industrialization
Online Access:	https://doi.org/10.1186/s11671-025-04200-2

Similar Items

Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics
by: Peter Bannas, et al.
Published: (2017-11-01)

Nanobodies: From Discovery to AI-Driven Design
by: Haoran Zhu, et al.
Published: (2025-05-01)

Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years
by: Elena Alexander, et al.
Published: (2024-10-01)

Nanobody‑horseradish peroxidase and -EGFP fusions as reagents to detect porcine parvovirus in the immunoassays
by: Qizhong Lu, et al.
Published: (2020-01-01)

Identification of Serum Ferritin-Specific Nanobodies and Development towards a Diagnostic Immunoassay
by: Yaozhong Hu, et al.
Published: (2022-08-01)

Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment
by: Jiewen Wang, et al.
Published: (2022-01-01)

A Novel Nanobody Directed against Ovine Myostatin to Enhance Muscle Growth in Mouse
by: Kepeng Ou, et al.
Published: (2020-08-01)

Nanobodies as Versatile Tool for Multiscale Imaging Modalities
by: Marco Erreni, et al.
Published: (2020-12-01)

Nanobodies as Diagnostic and Therapeutic Tools for Cardiovascular Diseases (CVDs)
by: Lorena-Andreea Bocancia-Mateescu, et al.
Published: (2023-06-01)

CDR1 Composition Can Affect Nanobody Recombinant Expression Yields
by: Marco Orlando, et al.
Published: (2021-09-01)

Applications of Nanobodies in Mycotoxin Detection
by: Shaowen WU, et al.
Published: (2022-11-01)

Computational nanobody design through deep generative modeling and epitope landscape profiling
by: Liyun Huo, et al.
Published: (2025-01-01)

Trends in the industry of clinical trials
by: S. S. Milovanov, et al.
Published: (2025-05-01)

Nanobodies as potential tools for microbiological testing of live biotherapeutic products
by: Robert J. Dorosky, et al.
Published: (2024-01-01)

NANOBODIES: STRUCTURE, MANUFACTURING, APPLICATION (REVIEW)
by: A. V. Shatalova, et al.
Published: (2019-02-01)

Exploring the nanobody patent landscape: a focus on BCMA sequences and structural analysis
by: Jiaqi Xu, et al.
Published: (2025-12-01)

Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology
by: Keming Lin, et al.
Published: (2024-04-01)

Pre-Clinical Intravenous Serum Pharmacokinetics of Albumin Binding and Non-Half-Life Extended Nanobodies®
by: Sven Hoefman, et al.
Published: (2015-07-01)

Structure of Nanobody Nb23
by: Mathias Percipalle, et al.
Published: (2021-06-01)

Nanobody and Its Therapeutic Applications
by: Maryam Darvish
Published: (2018-04-01)

Oligoclonal selection of nanobodies targeting vascular endothelial growth factor
by: Mehrdad Ahadi, et al.
Published: (2019-01-01)

Nanobodies: Next Generation of Cancer Diagnostics and Therapeutics
by: Emily Y. Yang, et al.
Published: (2020-07-01)

Development of an Anti-Zearalenone Nanobody Phage Display Library and Preparation of Specific Nanobodies
by: Ying Zeng, et al.
Published: (2025-02-01)

Monovalent, bivalent and biparatopic nanobodies targeting S1 protein of porcine epidemic diarrhea virus efficiently neutralized the virus infectivity
by: Huai-rui Qin, et al.
Published: (2024-07-01)

Prospects for the computational humanization of antibodies and nanobodies
by: Gemma L. Gordon, et al.
Published: (2024-05-01)

A general approach for stabilizing nanobodies for intracellular expression
by: John G Dingus, et al.
Published: (2022-11-01)

Domain swapping of complementarity-determining region in nanobodies produced by Pichia pastoris
by: Natsuko Miura, et al.
Published: (2019-07-01)

Recombinant PASylated nanobody probes with improved blood circulation and tumor targeting
by: Yicheng Yang, et al.
Published: (2025-05-01)

Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies
by: Mohadeseh Haji Abdolvahab, et al.
Published: (2024-02-01)

A nanobody-based blocking enzyme-linked immunosorbent assay for detecting antibodies against pseudorabies virus glycoprotein E
by: Huanhuan Lü, et al.
Published: (2024-04-01)

Nanobodies that Neutralize HIV
by: Robin A. Weiss, et al.
Published: (2019-07-01)

The Application of Nanobody in CAR-T Therapy
by: Chaolemeng Bao, et al.
Published: (2021-02-01)

In vitro and ex vivo proteomics of Mycobacterium marinum biofilms and the development of biofilm-binding synthetic nanobodies
by: Milka Marjut Hammarén, et al.
Published: (2023-06-01)

Preparation of Specific Nanobodies and Their Application in the Rapid Detection of Nodularin-R in Water Samples
by: Jinyi Yang, et al.
Published: (2021-11-01)

Selecting Nanobodies Specific for the Epidermal Growth Factor from a Synthetic Nanobody Library
by: Yunier Serrano-Rivero, et al.
Published: (2023-05-01)

A bivalent spike-targeting nanobody with anti-sarbecovirus activity
by: Iris C. Swart, et al.
Published: (2025-03-01)

Small but Mighty: Nanobodies in the Fight Against Infectious Diseases
by: Wenning Jiang, et al.
Published: (2025-04-01)

Nanobodies As Tools to Understand, Diagnose, and Treat African Trypanosomiasis
by: Benoit Stijlemans, et al.
Published: (2017-06-01)

Nanobody-based indirect competitive ELISA for the detection of aflatoxin M1 in dairy products
by: Li Yi, et al.
Published: (2025-01-01)

Visual and High-Efficiency Secretion of SARS-CoV-2 Nanobodies with <i>Escherichia coli</i>
by: Shuai Zhao, et al.
Published: (2025-01-01)